{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T06:07:14Z","timestamp":1767074834081,"version":"3.48.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04111-7","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:20:54Z","timestamp":1767028854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nomogram for survival prediction in metastatic differentiated thyroid cancer and survival comparison between systemic chemotherapy and local radiotherapy in high-risk patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Jian","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"11","key":"4111_CR1","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2213-8587(24)00223-7","volume":"12","author":"M Li","year":"2024","unstructured":"Li M, Dal Maso L, Pizzato M, Vaccarella S. Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study. Lancet Diabetes Endocrinol. 2024;12(11):824\u201336.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"4111_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","volume":"12","author":"CM Kitahara","year":"2016","unstructured":"Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646\u201353.","journal-title":"Nat Rev Endocrinol"},{"key":"4111_CR3","unstructured":"Howlader N, Krapcho ANM et al. SEER Cancer Statistics Review (CSR) 1975\u20132017."},{"issue":"10061","key":"4111_CR4","first-page":"2783","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG, Durante C. Thyroid Cancer Lancet. 2016;388(10061):2783\u201395.","journal-title":"Thyroid Cancer Lancet"},{"issue":"5","key":"4111_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338(5):297\u2013306.","journal-title":"N Engl J Med"},{"issue":"1","key":"4111_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12967-023-04277-2","volume":"21","author":"C Li","year":"2023","unstructured":"Li C, et al. Novel models by machine learning to predict prognosis of breast cancer brain metastases. J Transl Med. 2023;21(1):404.","journal-title":"J Transl Med"},{"key":"4111_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2025.104483","volume":"82","author":"C Li","year":"2025","unstructured":"Li C, Wang Y, Fang B, et al. Options for postoperative radiation therapy in patients with de novo metastatic breast cancer. Breast. 2025;82:104483.","journal-title":"Breast"},{"issue":"1","key":"4111_CR8","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1038\/s41598-025-88555-7","volume":"15","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, et al. Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy. Sci Rep. 2025;15(1):4045.","journal-title":"Sci Rep"},{"issue":"11","key":"4111_CR9","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.21037\/gs-24-313","volume":"13","author":"F Zheng","year":"2024","unstructured":"Zheng F, et al. Development and external validation of a nomogram to predict the prognosis of patients with metastatic prostate cancer who underwent radiotherapy. Gland Surg. 2024;13(11):2137\u201347.","journal-title":"Gland Surg"},{"key":"4111_CR10","doi-asserted-by":"crossref","unstructured":"Chen Z et al. Primary tumor resection with or without neck lymph node dissection as a viable initial therapy for medullary thyroid carcinoma with distant metastasis. Endocrine. 2024.","DOI":"10.1007\/s12020-024-04133-3"},{"issue":"20","key":"4111_CR11","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.7150\/jca.101293","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, et al. Deep neural network provides personalized treatment recommendations for de Novo metastatic breast cancer patients. J Cancer. 2024;15(20):6668\u201385.","journal-title":"J Cancer"},{"issue":"1","key":"4111_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"issue":"8","key":"4111_CR13","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91(8):2892\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4111_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"Cooper DS, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167\u2013214.","journal-title":"Thyroid"},{"issue":"1","key":"4111_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2265.2005.02304.x","volume":"63","author":"M Haq","year":"2005","unstructured":"Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf). 2005;63(1):87\u201393.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"4111_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1089\/thy.2011.0429","volume":"22","author":"MM Sabra","year":"2012","unstructured":"Sabra MM, et al. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans. Thyroid. 2012;22(9):877\u201383.","journal-title":"Thyroid"},{"issue":"5","key":"4111_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0002-9610(97)00158-X","volume":"174","author":"R Shaha","year":"1997","unstructured":"Shaha R, Shah AJP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg. 1997;174(5):474\u20136.","journal-title":"Am J Surg"},{"issue":"12","key":"4111_CR18","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2019;30(12):1856\u201383.","journal-title":"Ann Oncol"},{"issue":"1","key":"4111_CR19","volume":"10","author":"WQ Che","year":"2023","unstructured":"Che WQ, Li YJ, Tsang CK, et al. How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology. Mil Med Res. 2023;10(1):50.","journal-title":"Mil Med Res"},{"issue":"6","key":"4111_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s00268-005-0472-4","volume":"30","author":"CA Benbassat","year":"2006","unstructured":"Benbassat CA, Mechlis-Frish S, Hirsch D. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer. World J Surg. 2006;30(6):1088\u201395.","journal-title":"World J Surg"},{"issue":"4","key":"4111_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","volume":"86","author":"EL Mazzaferri","year":"2001","unstructured":"Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86(4):1447\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"4111_CR22","doi-asserted-by":"crossref","unstructured":"Osorio M, et al. Systematic review of site distribution of bone metastases in differentiated thyroid cancer. Head & Neck. 2017:39.","DOI":"10.1002\/hed.24655"},{"issue":"4","key":"4111_CR23","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1210\/jc.2014-4332","volume":"100","author":"E Ruel","year":"2015","unstructured":"Ruel E, et al. Adjuvant radioactive iodine therapy is associated with improved survival for patients with Intermediate-Risk papillary thyroid cancer. J Clin Endocrinol Metabolism. 2015;100(4):1529\u201336.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"7","key":"4111_CR24","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1210\/jc.2013-1059","volume":"98","author":"C Reiners","year":"2013","unstructured":"Reiners C, et al. Twenty-Five years after chernobyl: outcome of radioiodine treatment in children and adolescents with very High-Risk Radiation-Induced differentiated thyroid carcinoma. J Clin Endocrinol Metabolism. 2013;98(7):3039\u201348.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"4111_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1210\/jcem-67-3-501","volume":"67","author":"JJ Ruegemer","year":"1988","unstructured":"Ruegemer JJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab. 1988;67(3):501\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"4111_CR26","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/cncr.22956","volume":"110","author":"E Sampson","year":"2007","unstructured":"Sampson E, et al. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110(7):1451\u20136.","journal-title":"Cancer"},{"issue":"2","key":"4111_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cen.13489","volume":"88","author":"SY Sohn","year":"2018","unstructured":"Sohn SY, et al. Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up. Clin Endocrinol. 2018;88(2):318\u201326.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"4111_CR28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1507\/endocrj.EJ14-0181","volume":"61","author":"Y Ito","year":"2014","unstructured":"Ito Y, et al. Prognosis and prognostic factors of differentiated thyroid carcinoma after the appearance of metastasis refractory to radioactive iodine therapy. Endocr J. 2014;61(8):821\u20134.","journal-title":"Endocr J"},{"issue":"3","key":"4111_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/cen.12558","volume":"82","author":"S Chopra","year":"2015","unstructured":"Chopra S, et al. Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease-free survival. Clin Endocrinol (Oxf). 2015;82(3):445\u201352.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"4111_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1507\/endocrj.K10E-019","volume":"57","author":"Y Ito","year":"2010","unstructured":"Ito Y, et al. Prognosis and prognostic factors of patients with papillary carcinoma showing distant metastasis at surgery (M1 patients) in Japan. Endocr J. 2010;57(6):523\u201331.","journal-title":"Endocr J"},{"issue":"4","key":"4111_CR31","first-page":"598","volume":"37","author":"M Schlumberger","year":"1996","unstructured":"Schlumberger M, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996;37(4):598\u2013605.","journal-title":"J Nucl Med"},{"issue":"12","key":"4111_CR32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1089\/thy.2009.1611","volume":"19","author":"D Van Nostrand","year":"2009","unstructured":"Van Nostrand D. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer. Thyroid. 2009;19(12):1381\u201391.","journal-title":"Thyroid"},{"issue":"5","key":"4111_CR33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/thy.2008.0392","volume":"19","author":"AM Sawka","year":"2009","unstructured":"Sawka AM, et al. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid\u00ae. 2009;19(5):451\u20137.","journal-title":"Thyroid\u00ae"},{"issue":"5","key":"4111_CR34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S2213-8587(13)70215-8","volume":"2","author":"M Schlumberger","year":"2014","unstructured":"Schlumberger M, et al. Definition and management of radioactive iodine-refractory differentiated thyroid cancer. Lancet Diabetes Endocrinol. 2014;2(5):356\u20138.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"4111_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12020-020-02418-x","volume":"70","author":"A Campenn\u00ec","year":"2020","unstructured":"Campenn\u00ec A, et al. Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts. Endocrine. 2020;70(2):280\u201391.","journal-title":"Endocrine"},{"key":"4111_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1528392","volume":"16","author":"L Huang","year":"2025","unstructured":"Huang L, He L, Chen R, Liao S. A machine learning model for predicting bone and\/or lung metastasis in differentiated thyroid carcinoma: enhancing precision in risk stratification. Front Endocrinol (Lausanne). 2025;16:1528392.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4111_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12672-024-01703-9","volume":"16","author":"Y Sun","year":"2025","unstructured":"Sun Y, Lin D, Deng X, Zhang Y. Machine learning-based prognostic model for patients with anaplastic thyroid carcinoma. Discov Oncol. 2025;16(1):70. Published 2025 Jan 21.","journal-title":"Discov Oncol"},{"issue":"11","key":"4111_CR38","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.21037\/gs-24-481","volume":"13","author":"H Shen","year":"2024","unstructured":"Shen H, Yang C, Wang Y, et al. Development and validation of machine learning models for predicting lung metastasis risk in differentiated thyroid cancer based on two databases. Gland Surg. 2024;13(11):2174\u201388.","journal-title":"Gland Surg"},{"key":"4111_CR39","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.2147\/OTT.S160752","volume":"11","author":"J Tang","year":"2018","unstructured":"Tang J, et al. The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER. Onco Targets Ther. 2018;11:3551\u201360.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"4111_CR40","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1210\/jc.2013-1059","volume":"98","author":"C Reiners","year":"2013","unstructured":"Reiners C, et al. Twenty-five years after chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2013;98(7):3039\u201348.","journal-title":"J Clin Endocrinol Metab"},{"key":"4111_CR41","doi-asserted-by":"crossref","unstructured":"Giovanella L et al. Molecular imaging and theragnostics of thyroid cancers. Cancers (Basel). 2022;14(5).","DOI":"10.3390\/cancers14051272"},{"issue":"1","key":"4111_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.radonc.2017.05.010","volume":"124","author":"L Drost","year":"2017","unstructured":"Drost L, et al. Efficacy of postoperative radiation treatment for bone metastases in the extremities. Radiother Oncol. 2017;124(1):45\u20138.","journal-title":"Radiother Oncol"},{"issue":"9940","key":"4111_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","volume":"384","author":"MS Brose","year":"2014","unstructured":"Brose MS, et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet. 2014;384(9940):319\u201328.","journal-title":"Lancet"},{"issue":"7","key":"4111_CR44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1406470","volume":"372","author":"M Schlumberger","year":"2015","unstructured":"Schlumberger M, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015;372(7):621\u201330.","journal-title":"N Engl J Med"},{"issue":"7","key":"4111_CR45","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1089\/thy.2016.0650","volume":"27","author":"Z Yang","year":"2017","unstructured":"Yang Z, et al. Comparison of survival outcomes following postsurgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma. Thyroid\u00ae. 2017;27(7):944\u201352.","journal-title":"Thyroid\u00ae"},{"issue":"6","key":"4111_CR46","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.clon.2010.03.014","volume":"22","author":"SI Sherman","year":"2010","unstructured":"Sherman SI. Cytotoxic chemotherapy for differentiated thyroid carcinoma. Clin Oncol. 2010;22(6):464\u20138.","journal-title":"Clin Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04111-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04111-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T06:05:29Z","timestamp":1767074729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04111-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4111"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04111-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"type":"electronic","value":"1477-7819"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval were waived for this study due to the fact that the data are fully de-identified and no intervention on patients was performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}